Journal for ImmunoTherapy of Cancer (Sep 2021)

Immune cell and tumor cell-derived CXCL10 is indicative of immunotherapy response in metastatic melanoma

  • Thomas F Gajewski,
  • Ken Hatogai,
  • Robin Reschke,
  • Jovian Yu,
  • Emily F Higgs,
  • Blake A Flood

DOI
https://doi.org/10.1136/jitc-2021-003521
Journal volume & issue
Vol. 9, no. 9

Abstract

Read online

No abstracts available.